319 related articles for article (PubMed ID: 34607031)
1. Presence of pharmaceuticals and their metabolites in wild-living aquatic organisms - Current state of knowledge.
Świacka K; Maculewicz J; Kowalska D; Caban M; Smolarz K; Świeżak J
J Hazard Mater; 2022 Feb; 424(Pt A):127350. PubMed ID: 34607031
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
Mezzelani M; Gorbi S; Regoli F
Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
[TBL] [Abstract][Full Text] [Related]
3. Levels and effects of antidepressant drugs to aquatic organisms.
Moreira DG; Aires A; de Lourdes Pereira M; Oliveira M
Comp Biochem Physiol C Toxicol Pharmacol; 2022 Jun; 256():109322. PubMed ID: 35272041
[TBL] [Abstract][Full Text] [Related]
4. Health effects and risks associated with the occurrence of pharmaceuticals and their metabolites in marine organisms and seafood.
Madikizela LM; Ncube S
Sci Total Environ; 2022 Sep; 837():155780. PubMed ID: 35537516
[TBL] [Abstract][Full Text] [Related]
5. Bioaccumulation/bioconcentration of pharmaceutical active compounds in aquatic organisms: Assessment and factors database.
Gómez-Regalado MDC; Martín J; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
Sci Total Environ; 2023 Feb; 861():160638. PubMed ID: 36473663
[TBL] [Abstract][Full Text] [Related]
6. Determination of the pharmaceuticals-nano/microplastics in aquatic systems by analytical and instrumental methods.
Pashaei R; Dzingelevičienė R; Abbasi S; Szultka-Młyńska M; Buszewski B
Environ Monit Assess; 2022 Jan; 194(2):93. PubMed ID: 35028740
[TBL] [Abstract][Full Text] [Related]
7. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
[TBL] [Abstract][Full Text] [Related]
8. Emerging challenges of the impacts of pharmaceuticals on aquatic ecosystems: A diatom perspective.
Kock A; Glanville HC; Law AC; Stanton T; Carter LJ; Taylor JC
Sci Total Environ; 2023 Jun; 878():162939. PubMed ID: 36934940
[TBL] [Abstract][Full Text] [Related]
9. Spatial (bio)accumulation of pharmaceuticals, illicit drugs, plasticisers, perfluorinated compounds and metabolites in river sediment, aquatic plants and benthic organisms.
Wilkinson JL; Hooda PS; Swinden J; Barker J; Barton S
Environ Pollut; 2018 Mar; 234():864-875. PubMed ID: 29248854
[TBL] [Abstract][Full Text] [Related]
10. Colloids as a sink for certain pharmaceuticals in the aquatic environment.
Maskaoui K; Zhou JL
Environ Sci Pollut Res Int; 2010 May; 17(4):898-907. PubMed ID: 20024675
[TBL] [Abstract][Full Text] [Related]
11. The Biological Effects of Pharmaceuticals in the Marine Environment.
Mezzelani M; Regoli F
Ann Rev Mar Sci; 2022 Jan; 14():105-128. PubMed ID: 34425054
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals in biota in the aquatic environment: analytical methods and environmental implications.
Huerta B; Rodríguez-Mozaz S; Barceló D
Anal Bioanal Chem; 2012 Nov; 404(9):2611-24. PubMed ID: 22678760
[TBL] [Abstract][Full Text] [Related]
13. An Overview of Analytical Methods to Determine Pharmaceutical Active Compounds in Aquatic Organisms.
Gómez-Regalado MDC; Martín-Pozo L; Martín J; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364408
[TBL] [Abstract][Full Text] [Related]
14. Microplastics in aquatic environments: Implications for Canadian ecosystems.
Anderson JC; Park BJ; Palace VP
Environ Pollut; 2016 Nov; 218():269-280. PubMed ID: 27431693
[TBL] [Abstract][Full Text] [Related]
15. Occurrence, detection and ecotoxicity studies of selected pharmaceuticals in aqueous ecosystems- a systematic appraisal.
Omotola EO; Oluwole AO; Oladoye PO; Olatunji OS
Environ Toxicol Pharmacol; 2022 Apr; 91():103831. PubMed ID: 35151848
[TBL] [Abstract][Full Text] [Related]
16. Occurrence, bioaccumulation and toxicological effect of drugs of abuse in aquatic ecosystem: A review.
Chen L; Guo C; Sun Z; Xu J
Environ Res; 2021 Sep; 200():111362. PubMed ID: 34048744
[TBL] [Abstract][Full Text] [Related]
17. Occurrence, fate and effects of azoxystrobin in aquatic ecosystems: a review.
Rodrigues ET; Lopes I; Pardal MÂ
Environ Int; 2013 Mar; 53():18-28. PubMed ID: 23314040
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
[TBL] [Abstract][Full Text] [Related]
19. A review of the pharmaceutical exposome in aquatic fauna.
Miller TH; Bury NR; Owen SF; MacRae JI; Barron LP
Environ Pollut; 2018 Aug; 239():129-146. PubMed ID: 29653304
[TBL] [Abstract][Full Text] [Related]
20. Updated knowledge, partitioning and ecological risk of pharmaceuticals and personal care products in global aquatic environments.
Chaves MJS; Kulzer J; Pujol de Lima PDR; Barbosa SC; Primel EG
Environ Sci Process Impacts; 2022 Nov; 24(11):1982-2008. PubMed ID: 36124562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
